Hovione is the World's leading producer of generic contrast media agents. We are the largest producer of these compounds offering bulk product to third-parties. Hovione's bulk iopamidol was present in the first generic formulations to be put on sale in Japan (June 1996), in the USA (November 1996), and in Germany (December 1996). We have the Certificate of Suitability of the European Pharmacopeia available for iopamidol, click here.

We have developed independent and cost-effective processes for the production of iopamidol and iohexol. The role of Hovione in the world of radiology is to enable generic houses to offer quality and cost-effective, equivalent, contrast media agents after patents expire.

Hovione has chosen to enter the field of contrast media because of its technical difficulty, it is part of our strategy to seek and solve technical challenges where the commercial reward is interesting. We are keen to assist equally competent companies active in the business of manufacture of injectable formulations and/or in the hospital product distribution business to enter this challenging but rewarding market.

For further information please contact Carla Vozone at
Marketing and Sales Department
Tel: + 351 21 9829245
Fax: + 352 21 9829388